Form EFFECT Zivo Bioscience, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 1, 2026 |
| Accession Number: | 0001654954-26-002983 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Triton Ventures Announces Expansion of the Triton-Verse to Advance AI Literacy, Workforce Readiness With Emergent Technology, and Human AI Collaboration
- Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
- Noemi Professional US Announces Dual Runner Up Honors for Noemi Innovate at the 2026 ASCP Skin Deep Readers' Choice Awards
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
